clinical trials for glp-1 obesity meds actively recruiting Pharmacology Consult: receptor agonists weight loss management 📣 NOW RECRUITING: New Clinical

GLP-1 RAs reduce glycated hemoglobin (HbA1c: Hemoglobin A1C) with low hypoglycemia risk and lead to clinically relevant reductions in weight, body mass index, and waist circumference in overweight or obese individuals, with or without diabetes

CT-996 has been designed to have biased signaling on the GLP-1 receptor

One fact untangles most of the confusion in any list of GLP-1 medications: the same molecule is often sold under two different brand names, one approved for type 2 diabetes and one for weight management

Sometimes you need to tip the pen body slightly and let gravity help

As a metabolic neuroscientist specializing in the neuroendocrine control of energy balance and the metabolic dysregulation that accompanies obesity, Geisler was interested in the role of glial cells specifically tanycytes and astrocytes